LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 10 of total 21

Search options

  1. Article ; Online: Quantification of Infectious SARS-CoV-2 by the 50% Tissue Culture Infectious Dose Endpoint Dilution Assay.

    Bullen, C Korin / Davis, Stephanie L / Looney, Monika M

    Methods in molecular biology (Clifton, N.J.)

    2022  Volume 2452, Page(s) 131–146

    Abstract: A number of viral quantification methods are used to measure the concentration of infectious severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). While the traditional plaque-based assay allows for direct enumeration of replication competent ... ...

    Abstract A number of viral quantification methods are used to measure the concentration of infectious severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). While the traditional plaque-based assay allows for direct enumeration of replication competent lytic virions and remains the gold standard for the quantification of infectious virus, the 50% tissue culture infectious dose (TCID
    MeSH term(s) Animals ; Biological Assay/methods ; COVID-19 ; Communicable Diseases ; Cytopathogenic Effect, Viral ; SARS-CoV-2
    Language English
    Publishing date 2022-05-12
    Publishing country United States
    Document type Journal Article ; Research Support, Non-U.S. Gov't
    ISSN 1940-6029
    ISSN (online) 1940-6029
    DOI 10.1007/978-1-0716-2111-0_9
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article ; Online: MDA5 RNA-sensing pathway activation by Mycobacterium tuberculosis promotes innate immune subversion and pathogen survival.

    Bullen, C Korin / Singh, Alok K / Krug, Stefanie / Lun, Shichun / Thakur, Preeti / Srikrishna, Geetha / Bishai, William R

    JCI insight

    2023  Volume 8, Issue 20

    Abstract: Host cytosolic sensing of Mycobacterium tuberculosis (M. tuberculosis) RNA by the RIG-I-like receptor (RLR) family perturbs innate immune control within macrophages; however, a distinct role of MDA5, a member of the RLR family, in M. tuberculosis ... ...

    Abstract Host cytosolic sensing of Mycobacterium tuberculosis (M. tuberculosis) RNA by the RIG-I-like receptor (RLR) family perturbs innate immune control within macrophages; however, a distinct role of MDA5, a member of the RLR family, in M. tuberculosis pathogenesis has yet to be fully elucidated. To further define the role of MDA5 in M. tuberculosis pathogenesis, we evaluated M. tuberculosis intracellular growth and innate immune responses in WT and Mda5-/- macrophages. Transfection of M. tuberculosis RNA strongly induced proinflammatory cytokine production in WT macrophages, which was abrogated in Mda5-/- macrophages. M. tuberculosis infection in macrophages induced MDA5 protein expression, accompanied by an increase in MDA5 activation as assessed by multimer formation. IFN-γ-primed Mda5-/- macrophages effectively contained intracellular M. tuberculosis proliferation to a markedly greater degree than WT macrophages. Further comparisons of WT versus Mda5-/- macrophages revealed that during M. tuberculosis infection MDA5 contributed to IL-1β production and inflammasome activation and that loss of MDA5 led to a substantial increase in autophagy. In the mouse TB model, loss of MDA5 conferred host survival benefits with a concomitant reduction in M. tuberculosis bacillary burden. These data reveal that loss of MDA5 is host protective during M. tuberculosis infection in vitro and in vivo, suggesting that M. tuberculosis exploits MDA5 to subvert immune containment.
    MeSH term(s) Animals ; Mice ; Immunity, Innate ; Macrophages ; Mycobacterium tuberculosis ; RNA ; Tuberculosis
    Chemical Substances RNA (63231-63-0) ; Ifih1 protein, mouse (EC 3.6.1.-)
    Language English
    Publishing date 2023-10-23
    Publishing country United States
    Document type Journal Article
    ISSN 2379-3708
    ISSN (online) 2379-3708
    DOI 10.1172/jci.insight.166242
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Article ; Online: MDA5 RNA-sensing pathway activation by Mycobacterium tuberculosis promotes innate immune subversion and pathogen survival

    C. Korin Bullen / Alok K. Singh / Stefanie Krug / Shichun Lun / Preeti Thakur / Geetha Srikrishna / William R. Bishai

    JCI Insight, Vol 8, Iss

    2023  Volume 20

    Abstract: Host cytosolic sensing of Mycobacterium tuberculosis (M. tuberculosis) RNA by the RIG-I–like receptor (RLR) family perturbs innate immune control within macrophages; however, a distinct role of MDA5, a member of the RLR family, in M. tuberculosis ... ...

    Abstract Host cytosolic sensing of Mycobacterium tuberculosis (M. tuberculosis) RNA by the RIG-I–like receptor (RLR) family perturbs innate immune control within macrophages; however, a distinct role of MDA5, a member of the RLR family, in M. tuberculosis pathogenesis has yet to be fully elucidated. To further define the role of MDA5 in M. tuberculosis pathogenesis, we evaluated M. tuberculosis intracellular growth and innate immune responses in WT and Mda5–/– macrophages. Transfection of M. tuberculosis RNA strongly induced proinflammatory cytokine production in WT macrophages, which was abrogated in Mda5–/– macrophages. M. tuberculosis infection in macrophages induced MDA5 protein expression, accompanied by an increase in MDA5 activation as assessed by multimer formation. IFN-γ–primed Mda5–/– macrophages effectively contained intracellular M. tuberculosis proliferation to a markedly greater degree than WT macrophages. Further comparisons of WT versus Mda5–/– macrophages revealed that during M. tuberculosis infection MDA5 contributed to IL-1β production and inflammasome activation and that loss of MDA5 led to a substantial increase in autophagy. In the mouse TB model, loss of MDA5 conferred host survival benefits with a concomitant reduction in M. tuberculosis bacillary burden. These data reveal that loss of MDA5 is host protective during M. tuberculosis infection in vitro and in vivo, suggesting that M. tuberculosis exploits MDA5 to subvert immune containment.
    Keywords Immunology ; Infectious disease ; Medicine ; R
    Language English
    Publishing date 2023-10-01T00:00:00Z
    Publisher American Society for Clinical investigation
    Document type Article ; Online
    Database BASE - Bielefeld Academic Search Engine (life sciences selection)

    More links

    Kategorien

  4. Article ; Online: Genome editing of human embryos: to edit or not to edit, that is the question.

    Chandrasegaran, Srinivasan / Bullen, C Korin / Carroll, Dana

    The Journal of clinical investigation

    2017  Volume 127, Issue 10, Page(s) 3588–3590

    MeSH term(s) Blastocyst ; Cardiomyopathy, Hypertrophic, Familial/genetics ; Cardiomyopathy, Hypertrophic, Familial/therapy ; Carrier Proteins/genetics ; Carrier Proteins/metabolism ; Gene Editing/methods ; Gene Editing/trends ; Germ-Line Mutation ; Humans
    Chemical Substances Carrier Proteins ; myosin-binding protein C
    Language English
    Publishing date 2017-08-28
    Publishing country United States
    Document type Journal Article ; Editorial
    ZDB-ID 3067-3
    ISSN 1558-8238 ; 0021-9738
    ISSN (online) 1558-8238
    ISSN 0021-9738
    DOI 10.1172/JCI96962
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  5. Article ; Online: Nucleolin mediates SARS-CoV-2 replication and viral-induced apoptosis of host cells.

    Merino, Vanessa F / Yan, Yu / Ordonez, Alvaro A / Bullen, C Korin / Lee, Albert / Saeki, Harumi / Ray, Krishanu / Huang, Tao / Jain, Sanjay K / Pomper, Martin G

    Antiviral research

    2023  Volume 211, Page(s) 105550

    Abstract: Host-oriented antiviral therapeutics are promising treatment options to combat COVID-19 and its emerging variants. However, relatively little is known about the cellular proteins hijacked by SARS-CoV-2 for its replication. Here we show that SARS-CoV-2 ... ...

    Abstract Host-oriented antiviral therapeutics are promising treatment options to combat COVID-19 and its emerging variants. However, relatively little is known about the cellular proteins hijacked by SARS-CoV-2 for its replication. Here we show that SARS-CoV-2 induces expression and cytoplasmic translocation of the nucleolar protein, nucleolin (NCL). NCL interacts with SARS-CoV-2 viral proteins and co-localizes with N-protein in the nucleolus and in stress granules. Knockdown of NCL decreases the stress granule component G3BP1, viral replication and improved survival of infected host cells. NCL mediates viral-induced apoptosis and stress response via p53. SARS-CoV-2 increases NCL expression and nucleolar size and number in lungs of infected hamsters. Inhibition of NCL with the aptamer AS-1411 decreases viral replication and apoptosis of infected cells. These results suggest nucleolin as a suitable target for anti-COVID therapies.
    MeSH term(s) Humans ; SARS-CoV-2/metabolism ; DNA Helicases ; RNA Recognition Motif Proteins ; Poly-ADP-Ribose Binding Proteins ; RNA Helicases/metabolism ; COVID-19 ; Phosphoproteins/metabolism ; Apoptosis ; Virus Replication ; Nucleolin
    Chemical Substances DNA Helicases (EC 3.6.4.-) ; RNA Recognition Motif Proteins ; Poly-ADP-Ribose Binding Proteins ; RNA Helicases (EC 3.6.4.13) ; Phosphoproteins ; G3BP1 protein, human (EC 3.6.4.12)
    Language English
    Publishing date 2023-02-03
    Publishing country Netherlands
    Document type Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 306628-9
    ISSN 1872-9096 ; 0166-3542
    ISSN (online) 1872-9096
    ISSN 0166-3542
    DOI 10.1016/j.antiviral.2023.105550
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  6. Article ; Online: Relative and Quantitative Phosphoproteome Analysis of Macrophages in Response to Infection by Virulent and Avirulent

    Choudhary, Eira / Bullen, C Korin / Goel, Renu / Singh, Alok Kumar / Praharaj, Monali / Thakur, Preeti / Dhiman, Rohan / Bishai, William R / Agarwal, Nisheeth

    Journal of proteome research

    2020  Volume 19, Issue 6, Page(s) 2316–2336

    Abstract: Comparative phosphoproteomics ... ...

    Abstract Comparative phosphoproteomics of
    MeSH term(s) Humans ; Macrophages ; Mycobacterium bovis ; Mycobacterium tuberculosis ; RNA ; Tandem Mass Spectrometry
    Chemical Substances RNA (63231-63-0)
    Language English
    Publishing date 2020-05-14
    Publishing country United States
    Document type Journal Article ; Research Support, N.I.H., Extramural ; Research Support, Non-U.S. Gov't
    ZDB-ID 2078618-9
    ISSN 1535-3907 ; 1535-3893
    ISSN (online) 1535-3907
    ISSN 1535-3893
    DOI 10.1021/acs.jproteome.9b00895
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  7. Article ; Online: Intravenous BCG vaccination reduces SARS-CoV-2 severity and promotes extensive reprogramming of lung immune cells.

    Singh, Alok K / Wang, Rulin / Lombardo, Kara A / Praharaj, Monali / Bullen, C Korin / Um, Peter / Gupta, Manish / Srikrishna, Geetha / Davis, Stephanie / Komm, Oliver / Illei, Peter B / Ordonez, Alvaro A / Bahr, Melissa / Huang, Joy / Gupta, Anuj / Psoter, Kevin J / Creisher, Patrick S / Li, Maggie / Pekosz, Andrew /
    Klein, Sabra L / Jain, Sanjay K / Bivalacqua, Trinity J / Yegnasubramanian, Srinivasan / Bishai, William R

    iScience

    2023  Volume 26, Issue 10, Page(s) 107733

    Abstract: Bacillus Calmette-Guérin (BCG) confers heterologous immune protection against viral infections and has been proposed as vaccine against SARS-CoV-2 (SCV2). Here, we tested intravenous BCG vaccination against COVID-19 using the golden Syrian hamster model. ...

    Abstract Bacillus Calmette-Guérin (BCG) confers heterologous immune protection against viral infections and has been proposed as vaccine against SARS-CoV-2 (SCV2). Here, we tested intravenous BCG vaccination against COVID-19 using the golden Syrian hamster model. BCG vaccination conferred a modest reduction on lung SCV2 viral load, bronchopneumonia scores, and weight loss, accompanied by a reversal of SCV2-mediated T cell lymphopenia, and reduced lung granulocytes. BCG uniquely recruited immunoglobulin-producing plasma cells to the lung suggesting accelerated local antibody production. BCG vaccination also recruited elevated levels of Th1, Th17, Treg, CTLs, and Tmem cells, with a transcriptional shift away from exhaustion markers and toward antigen presentation and repair. Similarly, BCG enhanced recruitment of alveolar macrophages and reduced key interstitial macrophage subsets, that show reduced IFN-associated gene expression. Our observations indicate that BCG vaccination protects against SCV2 immunopathology by promoting early lung immunoglobulin production and immunotolerizing transcriptional patterns among key myeloid and lymphoid populations.
    Language English
    Publishing date 2023-08-24
    Publishing country United States
    Document type Journal Article
    ISSN 2589-0042
    ISSN (online) 2589-0042
    DOI 10.1016/j.isci.2023.107733
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  8. Article: Dynamic single-cell RNA sequencing reveals BCG vaccination curtails SARS-CoV-2 induced disease severity and lung inflammation.

    Singh, Alok K / Wang, Rulin / Lombardo, Kara A / Praharaj, Monali / Bullen, C Korin / Um, Peter / Davis, Stephanie / Komm, Oliver / Illei, Peter B / Ordonez, Alvaro A / Bahr, Melissa / Huang, Joy / Gupta, Anuj / Psoter, Kevin J / Jain, Sanjay K / Bivalacqua, Trinity J / Yegnasubramanian, Srinivasan / Bishai, William R

    bioRxiv : the preprint server for biology

    2022  

    Abstract: COVID-19 continues to exact a toll on human health despite the availability of several vaccines. Bacillus Calmette Guérin (BCG) has been shown to confer heterologous immune protection against viral infections including COVID-19 and has been proposed as ... ...

    Abstract COVID-19 continues to exact a toll on human health despite the availability of several vaccines. Bacillus Calmette Guérin (BCG) has been shown to confer heterologous immune protection against viral infections including COVID-19 and has been proposed as vaccine against SARS-CoV-2 (SCV2). Here we tested intravenous BCG vaccination against COVID-19 using the golden Syrian hamster model together with immune profiling and single cell RNA sequencing (scRNAseq). We observed that BCG reduced both lung SCV2 viral load and bronchopneumonia. This was accompanied by an increase in lung alveolar macrophages, a reversal of SCV2-mediated T cell lymphopenia, and reduced lung granulocytes. Single cell transcriptome profiling showed that BCG uniquely recruits immunoglobulin-producing plasma cells to the lung suggesting accelerated antibody production. BCG vaccination also recruited elevated levels of Th1, Th17, Treg, CTLs, and Tmem cells, and differentially expressed gene (DEG) analysis showed a transcriptional shift away from exhaustion markers and towards antigen presentation and repair. Similarly, BCG enhanced lung recruitment of alveolar macrophages and reduced key interstitial macrophage subsets, with both cell-types also showing reduced IFN-associated gene expression. Our observations indicate that BCG vaccination protects against SCV2 immunopathology by promoting early lung immunoglobulin production and immunotolerizing transcriptional patterns among key myeloid and lymphoid populations.
    Language English
    Publishing date 2022-03-15
    Publishing country United States
    Document type Preprint
    DOI 10.1101/2022.03.15.484018
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  9. Article ; Online: Sulforaphane exhibits antiviral activity against pandemic SARS-CoV-2 and seasonal HCoV-OC43 coronaviruses in vitro and in mice.

    Ordonez, Alvaro A / Bullen, C Korin / Villabona-Rueda, Andres F / Thompson, Elizabeth A / Turner, Mitchell L / Merino, Vanessa F / Yan, Yu / Kim, John / Davis, Stephanie L / Komm, Oliver / Powell, Jonathan D / D'Alessio, Franco R / Yolken, Robert H / Jain, Sanjay K / Jones-Brando, Lorraine

    Communications biology

    2022  Volume 5, Issue 1, Page(s) 242

    Abstract: Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), the cause of coronavirus disease 2019 (COVID-19), has incited a global health crisis. Currently, there are limited therapeutic options for the prevention and treatment of SARS-CoV-2 infections. ...

    Abstract Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), the cause of coronavirus disease 2019 (COVID-19), has incited a global health crisis. Currently, there are limited therapeutic options for the prevention and treatment of SARS-CoV-2 infections. We evaluated the antiviral activity of sulforaphane (SFN), the principal biologically active phytochemical derived from glucoraphanin, the naturally occurring precursor present in high concentrations in cruciferous vegetables. SFN inhibited in vitro replication of six strains of SARS-CoV-2, including Delta and Omicron, as well as that of the seasonal coronavirus HCoV-OC43. Further, SFN and remdesivir interacted synergistically to inhibit coronavirus infection in vitro. Prophylactic administration of SFN to K18-hACE2 mice prior to intranasal SARS-CoV-2 infection significantly decreased the viral load in the lungs and upper respiratory tract and reduced lung injury and pulmonary pathology compared to untreated infected mice. SFN treatment diminished immune cell activation in the lungs, including significantly lower recruitment of myeloid cells and a reduction in T cell activation and cytokine production. Our results suggest that SFN should be explored as a potential agent for the prevention or treatment of coronavirus infections.
    MeSH term(s) Adenosine Monophosphate/analogs & derivatives ; Adenosine Monophosphate/therapeutic use ; Alanine/analogs & derivatives ; Alanine/therapeutic use ; Animals ; Antiviral Agents/therapeutic use ; Caco-2 Cells ; Chlorocebus aethiops ; Common Cold/drug therapy ; Common Cold/virology ; Coronavirus Infections/drug therapy ; Coronavirus Infections/immunology ; Coronavirus Infections/virology ; Coronavirus OC43, Human ; Cytokines/immunology ; Drug Synergism ; Humans ; Isothiocyanates/therapeutic use ; Lung/immunology ; Lung/virology ; Macrophages, Alveolar/immunology ; Male ; Mice, Transgenic ; SARS-CoV-2 ; Spleen/immunology ; Sulfoxides/therapeutic use ; T-Lymphocytes/immunology ; Vero Cells ; Viral Load ; COVID-19 Drug Treatment
    Chemical Substances Antiviral Agents ; Cytokines ; Isothiocyanates ; Sulfoxides ; remdesivir (3QKI37EEHE) ; Adenosine Monophosphate (415SHH325A) ; sulforaphane (GA49J4310U) ; Alanine (OF5P57N2ZX)
    Language English
    Publishing date 2022-03-18
    Publishing country England
    Document type Journal Article
    ISSN 2399-3642
    ISSN (online) 2399-3642
    DOI 10.1038/s42003-022-03189-z
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  10. Article: Sulforaphane exhibits in vitro and in vivo antiviral activity against pandemic SARS-CoV-2 and seasonal HCoV-OC43 coronaviruses.

    Ordonez, Alvaro A / Bullen, C Korin / Villabona-Rueda, Andres F / Thompson, Elizabeth A / Turner, Mitchell L / Davis, Stephanie L / Komm, Oliver / Powell, Jonathan D / D'Alessio, Franco R / Yolken, Robert H / Jain, Sanjay K / Jones-Brando, Lorraine

    bioRxiv : the preprint server for biology

    2021  

    Abstract: Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), the cause of coronavirus disease 2019 (COVID-19), has incited a global health crisis. Currently, there are no orally available medications for prophylaxis for those exposed to SARS-CoV-2 and ... ...

    Abstract Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), the cause of coronavirus disease 2019 (COVID-19), has incited a global health crisis. Currently, there are no orally available medications for prophylaxis for those exposed to SARS-CoV-2 and limited therapeutic options for those who develop COVID-19. We evaluated the antiviral activity of sulforaphane (SFN), a naturally occurring, orally available, well-tolerated, nutritional supplement present in high concentrations in cruciferous vegetables with limited side effects. SFN inhibited in vitro replication of four strains of SARS-CoV-2 as well as that of the seasonal coronavirus HCoV-OC43. Further, SFN and remdesivir interacted synergistically to inhibit coronavirus infection in vitro. Prophylactic administration of SFN to K18-hACE2 mice prior to intranasal SARS-CoV-2 infection significantly decreased the viral load in the lungs and upper respiratory tract and reduced lung injury and pulmonary pathology compared to untreated infected mice. SFN treatment diminished immune cell activation in the lungs, including significantly lower recruitment of myeloid cells and a reduction in T cell activation and cytokine production. Our results suggest that SFN is a promising treatment for prevention of coronavirus infection or treatment of early disease.
    Language English
    Publishing date 2021-03-25
    Publishing country United States
    Document type Preprint
    DOI 10.1101/2021.03.25.437060
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top